SBC Medical Group (NASDAQ:SBC) Sets New 1-Year High on Analyst Upgrade

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) shares reached a new 52-week high on Monday after Wall Street Zen upgraded the stock from a buy rating to a strong-buy rating. The stock traded as high as $5.35 and last traded at $5.2570, with a volume of 59735 shares. The stock had previously closed at $5.09.

Several other analysts also recently weighed in on the company. BTIG Research reaffirmed a “buy” rating and set a $8.00 target price on shares of SBC Medical Group in a research note on Thursday, August 13th. Weiss Ratings upgraded SBC Medical Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, September 22nd. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $8.50.

Institutional Trading of SBC Medical Group

A number of hedge funds have recently modified their holdings of the business. State Street Corp grew its holdings in shares of SBC Medical Group by 59.7% during the second quarter. State Street Corp now owns 49,239 shares of the company’s stock valued at $152,000 after buying an additional 18,400 shares in the last quarter. Citadel Advisors LLC purchased a new stake in SBC Medical Group in the 2nd quarter worth about $446,000. Two Sigma Securities LLC purchased a new stake in SBC Medical Group in the 2nd quarter worth about $66,000. Bank of America Corp DE acquired a new stake in SBC Medical Group during the 2nd quarter worth about $35,000. Finally, BlackRock Inc. acquired a new stake in SBC Medical Group during the 2nd quarter worth about $2,846,000. Hedge funds and other institutional investors own 60.82% of the company’s stock.

SBC Medical Group Trading Down 0.2%

The company has a market cap of $548.19 million, a PE ratio of 11.34, a PEG ratio of 2.40 and a beta of 0.56. The company has a debt-to-equity ratio of 0.09, a quick ratio of 3.27 and a current ratio of 3.31. The company has a 50 day simple moving average of $4.13 and a two-hundred day simple moving average of $3.64.

SBC Medical Group (NASDAQ:SBC) last issued its earnings results on Thursday, August 13th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.02). The firm had revenue of $49.19 million during the quarter, compared to analyst estimates of $45.37 million. SBC Medical Group had a return on equity of 18.47% and a net margin of 27.99%. Sell-side analysts forecast that SBC Medical Group Holdings Incorporated will post 0.44 EPS for the current year.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is a healthcare company focused on supporting medical institutions, particularly clinics that provide aesthetic and cosmetic medical treatments. Its business includes management services, operational support and products designed to help medical providers deliver care and manage their practices.

The company is associated with the Shonan Beauty Clinic network, which offers services such as cosmetic surgery, dermatology, hair restoration and other aesthetic procedures.